Risk factors for fungal infection in paediatric liver transplant recipients

Pediatric Transplantation

Volumn 9, Issue 2, 2005, Pages 220-225

  Verma, Anita ^a   Wade, Jim J ^a   Cheeseman, Paul ^a   Samaroo, Beatrice ^a   Rela, Mohemmed ^a   Heaton, Nigel D ^a   Mieli Vergani, Giorgina ^a   Dhawan, Anil ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Antifungal; Children; Fungal infection; Liver transplantation; Risk factors

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B LIPID COMPLEX; AZATHIOPRINE; CEFTAZIDIME; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; ITRACONAZOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; TACROLIMUS; VORICONAZOLE;

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; BILE DUCT ATRESIA; CANDIDA; CANDIDA ALBICANS; CHILD; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; FEVER; FUNGAL COLONIZATION; HUMAN; INFANT; INTRAHEPATIC CHOLESTASIS; LIVER FAILURE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MYCOSIS; RISK FACTOR; TREATMENT INDICATION; VIRUS INFECTION;

ADOLESCENT; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER DISEASES; LIVER TRANSPLANTATION; MULTIVARIATE ANALYSIS; MYCOSES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 16444376136     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00295.x     Document Type: Article

References (37)

1. PAYA CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993: 16: 677.
2. PATEL R, PAYA CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997: 10: 86-124.
3. FUNG JJ. Fungal infection in liver transplantation. Transpl Infect Dis 2002: 4 (Suppl. 3): 18-23.
4. PATEL R, PORTELA D, BADLEY AD, HARMSEN WS, et al. Risk factors of invasive candida and non-candida fungal infections after liver transplantation. Transplantation 1996: 62: 926-934.
5. SINGH N, GAYOWSKI T, WAGNER MM, DOYLE H, MARINO IR. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin Infect Dis 1997: 24: 179-184.
6. HUSAIN S, TOLLEMAR J, DOMINGUEZ EA, et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 2003: 75: 2023-2029.
7. COLLINS LA, SAMORE MH, ROBERTS MS, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994: 170: 644-652.
8. TOLLEMAR J, ERICZON EB, BARKHOLT L, ANDERSSON J, RINGDEN O, GROTH CG. Risk factors of deep Candida infections in liver transplant recipients. Transplant Proc 1990: 22: 1826-1827.
9. CASTALDO P, STRATTA JR, WOOD PR, et al. Fungal disease in liver transplant recipients: a multivariate analysis. Transplant Proc 1991: 23: 1517-1519.
10. CHARLES P, WAJSZCZUK J, DUMMER S, et al. Fungal infections in liver transplant recipients. Transplantation 1985: 40: 347-353.
11. RABKIN JM, OROLOFF SL, CORLESS CL, et al. Association of fungal infection and increased mortality in liver transplant recipients. Am J Surg 2000: 179: 426-430.
12. BRIEGEL J, FORST H, SPILL B, et al. Risk factors for systemic fungal infections in liver transplant recipients. Eur J Clin Microbiol Infect Dis 1995: 14: 375-382.
13. WADE J, ROLANDO N, HAYLLAR K, et al. Bacterial and fungal infection after liver transplantation: an analysis of 284 patients. Hepatology 1995: 21: 1328-1336.
14. STEFFEN R, REINHARTZ O, BLUMHARDT G, et al. Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantation. Transpl Int 1994: 7: 101-108.
15. MORA NP, KLINTMALM GB, SOLOMON H, et al. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. Transplant Proc 1992: 24: 154-155.
16. SUGAR AM, SAUNDERS C, IDELSON BA, et al. Interaction of fluconazole and cyclosporine. Ann Intern Med 1989: 110: 844.
17. KENNEDY MS, DEEG HJ, SIEGEL M, CROWLEY JJ, STORB R, THOMAS ED. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. Transplantation 1983: 35: 211-215.
18. GLADDY AR, RICHARDSON ES, DAVIES HD, SUPERINA AR. Candida infection in pediatric liver transplant recipients. Liver Transpl Surg 1999: 5: 16-24.
19. BOUCHET J-C, STAMM D, BOILLOT O, LEPAPAE A, FLORET D. Postoperative infectious complications in paediatric liver transplantation: a study of 48 transplants. Paediatr Anaesth 2001: 11: 93-98.
20. DICTAR MO, MAJOLO E, ALEXANDER B, JACOB N, VERON MT. Mycoses in the transplanted patients. Med Mycol 2000: 38 (Suppl 1): 251-258.
21. PATTERSON JE. Epidemiology of fungal infections in solid organ transplant patients. Transpl Infect Dis 1999: 1: 229-236.
22. KOZINN PJ, TASCHDJIAN CL, GOLDBERG PK, WISE GJ, TONI EF, SHE MS. Advances in the diagnosis of renal candidiasis. J Urol 1978: 119: 184-187.
23. FISCHER JF, CHEW WH, SHADOMY S, DUMA RJ, MAYHALL CG, HOUSE WC. Urinary tract infections due to Candida albicans. Rev Infect Dis 1982: 4: 1107-1118.
24. WAJSZCZUK CP, DUMMER JS, HO M, et al. Fungal infections in liver transplant recipients. Transplantation 1985: 40: 347-353.
25. GRAUHAN O, LOHMANN R, LEMMENS P, et al. Fungal infection in liver transplant recipients. Langenbecks Arch Chir 1994: 379: 372-375.
26. KUSNE S, TOBIN D, PASCULLE AW, VAN THIEL DH, HO M, STARZEL TE. Candida carriage in the alimentary tract of liver transplant candidates. Transplantation 1994: 57: 398.
27. WENZEL RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995: 20: 1531.
28. PAYA CV, WIESNER RH, HERMANS PE, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation multivariate time-dependent analysis. J Hepatol 1993: 18: 185.
29. AGNER JA, Ross H, HUNT S, et al. Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation. Transplantation 1995: 60: 1473-1477.
30. HADLEY S, SAMORE MH, LEWIS WD, et al. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation 1995: 59: 851-859.
31. FORTUN J, MARTIN-DAVILA P, MORENOS S, et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl 2002: 8: 1065-1070.
32. TOLLEMAR J, HICKERSTEDT K, ERICZON BG, et al. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomised, placebo-controlled study. Transplantation 1995: 59: 45-50.
33. SINGH N, PATERSON DL, GAYOWSKI T, WAGENER MM, MARINO GR. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation 2001: 7: 910-913.
34. LUMBRERAS C, CUERVAS-MONS V, JARA P, et al. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis 1996: 174: 583-588.
35. WINSTON DJ, PAKRASI A, BUSUTTIL RW. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999: 131: 729-737.
36. SHARPE MD, GHENT C, GRANT D, HORBAY GL, MCDOUGAL J, COLBY W. Efficacy and safety of itraconazole for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Transplantation 2003: 76: 977-983.
37. WINSTON DJ, BUSUTTIL RW. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Transplantation 2002: 74: 688-695.